<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Krishnamurthy HK</submitter><pubmed_abstract>Tick-borne infections are the most common vector-borne diseases in the USA. Ticks harbor and transmit several infections with Lyme disease being the most common tickborne infection in the US and Europe. Lack of awareness about tick populations, specific diagnostic tests, and overlapping signs and symptoms of tick-borne infections can often lead to misdiagnosis affecting treatment and the prevalence data reported especially for non-Lyme tick-borne infections. The diagnostic tests currently available for tick-borne diseases are severely limited in their ability to provide accurate results and cannot detect multiple pathogens in a single run. The multiplex protein microarray developed at Vibrant was designed to detect multiple serological antibodies thereby detecting exposure to multiple path</pubmed_abstract><journal>Scientific reports</journal><pagination>2527</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11747503</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A customizable multiplex protein microarray for antibody testing and its application for tick-borne and other infectious diseases.</pubmed_title><pmcid>PMC11747503</pmcid><pubmed_authors>Bei K</pubmed_authors><pubmed_authors>Rajasekaran JJ</pubmed_authors><pubmed_authors>Krishnamurthy HK</pubmed_authors><pubmed_authors>Hedman K</pubmed_authors><pubmed_authors>Welc-Faleciak R</pubmed_authors><pubmed_authors>Blanton LS</pubmed_authors><pubmed_authors>Abdallah MAA</pubmed_authors><pubmed_authors>Changalath C</pubmed_authors><pubmed_authors>D'Angelo P</pubmed_authors><pubmed_authors>Ruzek D</pubmed_authors><pubmed_authors>Abu-Raddadi LJ</pubmed_authors><pubmed_authors>Fornara C</pubmed_authors><pubmed_authors>Furione M</pubmed_authors><pubmed_authors>Psaroulaki A</pubmed_authors><pubmed_authors>Matilda S</pubmed_authors><pubmed_authors>Fortova A</pubmed_authors><pubmed_authors>Jayaraman V</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Ntoula A</pubmed_authors><pubmed_authors>Krishna K</pubmed_authors><pubmed_authors>Lilleri D</pubmed_authors><pubmed_authors>Chrdle A</pubmed_authors><pubmed_authors>Pawelczyk A</pubmed_authors><pubmed_authors>Al-Sadeq DW</pubmed_authors><pubmed_authors>Nasrallah GK</pubmed_authors><pubmed_authors>Escarcega-Avila A</pubmed_authors><pubmed_authors>Soderlund-Venermo M</pubmed_authors><pubmed_authors>Makridaki E</pubmed_authors><pubmed_authors>Chochlakis D</pubmed_authors><pubmed_authors>Rai AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>A customizable multiplex protein microarray for antibody testing and its application for tick-borne and other infectious diseases.</name><description>Tick-borne infections are the most common vector-borne diseases in the USA. Ticks harbor and transmit several infections with Lyme disease being the most common tickborne infection in the US and Europe. Lack of awareness about tick populations, specific diagnostic tests, and overlapping signs and symptoms of tick-borne infections can often lead to misdiagnosis affecting treatment and the prevalence data reported especially for non-Lyme tick-borne infections. The diagnostic tests currently available for tick-borne diseases are severely limited in their ability to provide accurate results and cannot detect multiple pathogens in a single run. The multiplex protein microarray developed at Vibrant was designed to detect multiple serological antibodies thereby detecting exposure to multiple path</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T20:56:04.21Z</modification><creation>2025-04-04T20:56:04.21Z</creation></dates><accession>S-EPMC11747503</accession><cross_references><pubmed>39833196</pubmed><doi>10.1038/s41598-024-84467-0</doi></cross_references></HashMap>